{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:27:12Z","timestamp":1786793232585,"version":"build-2736575974"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472449"],"award-info":[{"award-number":["81472449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cyto.2024.156675","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T14:47:20Z","timestamp":1718722040000},"page":"156675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The CXCR2 chemokine receptor: A new target for gastric cancer therapy"],"prefix":"10.1016","volume":"181","author":[{"given":"Wenyan","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10251","key":"10.1016\/j.cyto.2024.156675_b0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0010","first-page":"87","article-title":"Global cancer statistics","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cyto.2024.156675_b0015","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.12659\/MSM.916475","article-title":"Recent advances in the surgical treatment of advanced gastric cancer: a review","volume":"25","author":"Tan","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"36","key":"10.1016\/j.cyto.2024.156675_b0020","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/onc.2017.108","article-title":"A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis","volume":"36","author":"Xiang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2024.156675_b0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.iy.12.040194.003113","article-title":"The molecular biology of leukocyte chemoattractant receptors","volume":"12","author":"Murphy","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2024.156675_b0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.cyto.2024.156675_b0035","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.cyto.2024.156675_b0040","doi-asserted-by":"crossref","first-page":"e33655","DOI":"10.1371\/journal.pone.0033655","article-title":"The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.cyto.2024.156675_b0045","doi-asserted-by":"crossref","first-page":"20545","DOI":"10.1074\/jbc.271.34.20545","article-title":"The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor","volume":"271","author":"Ahuja","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1432-1327.1998.2550067.x","article-title":"Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78","volume":"255","author":"Wuyts","year":"1998","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042168","article-title":"CXCR2 receptor: regulation of expression, signal transduction, and involvement in cancer","volume":"23","author":"Korbecki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156675_b0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2741\/1579","article-title":"The role of interleukin-8 in cancer cells and microenvironment interaction","volume":"10","author":"Yuan","year":"2005","journal-title":"Front Biosci"},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","article-title":"Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis","volume":"6","author":"Sparmann","year":"2004","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcb.240440403","article-title":"Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes","volume":"44","author":"Bordoni","year":"1990","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cyto.2024.156675_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0065-230X(10)06003-3","article-title":"CXC chemokines in cancer angiogenesis and metastases","volume":"106","author":"Keeley","year":"2010","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156675_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/REP-12-0153","article-title":"The emerging role of CXC chemokines in epithelial ovarian cancer","volume":"144","author":"Rainczuk","year":"2012","journal-title":"Reproduction"},{"issue":"6","key":"10.1016\/j.cyto.2024.156675_b0085","doi-asserted-by":"crossref","first-page":"L1094","DOI":"10.1152\/ajplung.2001.280.6.L1094","article-title":"IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways","volume":"280","author":"Schraufstatter","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156675_b0090","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1074\/jbc.M111.315762","article-title":"A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases","volume":"287","author":"Wu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2014.11.044","article-title":"CXCR2\/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K\/Akt\/GSK-3\u03b2\/Snail signaling","volume":"358","author":"Zhou","year":"2015","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1189\/jlb.0504306","article-title":"Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia","volume":"77","author":"Fuhler","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0105","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1074\/jbc.M006115200","article-title":"Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity\/growth-regulated protein involves the MEKK1\/p38 mitogen-activated protein kinase pathway","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cyto.2024.156675_b0110","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.onc.1208442","article-title":"KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway","volume":"24","author":"Burger","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2015.3234","article-title":"IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)","volume":"48","author":"Long","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cyto.2024.156675_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"21","key":"10.1016\/j.cyto.2024.156675_b0125","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0130","first-page":"289","article-title":"Potential roles and targeted therapy of the CXCLs\/CXCR2 axis in cancer and inflammatory diseases","volume":"1871","author":"Cheng","year":"2019","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.cyto.2024.156675_b0135","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-10-0483","article-title":"CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis","volume":"16","author":"Yang","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"Pt B","key":"10.1016\/j.cyto.2024.156675_b0140","article-title":"CXCL1 enhances COX-II expression in rheumatoid arthritis synovial fibroblasts by CXCR2, PLC, PKC, and NF-\u03baB signal pathway","volume":"124","author":"Hou","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2024.156675_b0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cyto.2024.156675_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","article-title":"Regulation of tumor metastasis by myeloid-derived suppressor cells","volume":"66","author":"Condamine","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.cyto.2024.156675_b0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/JLB.4MR0820-011R","article-title":"Brief review on the roles of neutrophils in cancer development","volume":"109","author":"Long","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156675_b0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156675_b0170","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer","volume":"124","author":"Eruslanov","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0175","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.31792","article-title":"Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cyto.2024.156675_b0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2024.156675_b0185","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI61067","article-title":"Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis","volume":"122","author":"Jamieson","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2024.156675_b0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fimmu.2012.00263","article-title":"CXCR2: from bench to bedside","volume":"3","author":"Stadtmann","year":"2012","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1535370213520110","article-title":"Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases","volume":"239","author":"Boppana","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"7","key":"10.1016\/j.cyto.2024.156675_b0200","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI41649","article-title":"CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow","volume":"120","author":"Eash","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.gastro.2012.09.057","article-title":"Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis","volume":"144","author":"Asfaha","year":"2013","journal-title":"Gastroenterology"},{"issue":"40","key":"10.1016\/j.cyto.2024.156675_b0210","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/sj.onc.1203820","article-title":"MGSA\/GRO-mediated melanocyte transformation involves induction of Ras expression","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1158\/0008-5472.CAN-08-3378","article-title":"Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis","volume":"69","author":"Singh","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cyto.2024.156675_b0220","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0002-9440(10)63580-8","article-title":"Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression","volume":"163","author":"Tazawa","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0225","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/SLA.0000000000002058","article-title":"Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer","volume":"267","author":"Zhang","year":"2018","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0240","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.cyto.2024.156675_b0245","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1158\/1078-0432.CCR-16-3122","article-title":"The promise of targeting macrophages in cancer therapy","volume":"23","author":"Brown","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12929-022-00881-4","article-title":"Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling","volume":"29","author":"Wang","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156675_b0255","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"17","key":"10.1016\/j.cyto.2024.156675_b0260","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined blockade of IL6 and PD-1\/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cyto.2024.156675_b0265","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/2159-8290.CD-13-1007","article-title":"The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNF\u03b1","volume":"4","author":"Smith","year":"2014","journal-title":"Cancer Discov."},{"issue":"23","key":"10.1016\/j.cyto.2024.156675_b0270","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.180331.111","article-title":"Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer","volume":"25","author":"Shree","year":"2011","journal-title":"Genes Dev."},{"issue":"17","key":"10.1016\/j.cyto.2024.156675_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713287","article-title":"Bioinformatic analysis of the CXCR2 Ligands in cancer processes","volume":"24","author":"Korbecki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cyto.2024.156675_b0280","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1158\/1078-0432.CCR-22-3273","article-title":"Dual role of CXCL8 in maintaining the mesenchymal state of glioblastoma stem cells and M2-like tumor-associated macrophages","volume":"29","author":"Yuan","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cyto.2024.156675_b0285","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.celrep.2019.07.068","article-title":"Re-education of tumor-associated macrophages by CXCR2 blockade drives senescence and tumor inhibition in advanced prostate cancer","volume":"28","author":"Di Mitri","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2024.156675_b0290","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2023.02.004","article-title":"Schwann cell-derived CXCL2 contributes to cancer pain by modulating macrophage infiltration in a mouse breast cancer model","volume":"109","author":"Zhang","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.cyto.2024.156675_b0295","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1136\/gutjnl-2021-325137","article-title":"Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT","volume":"71","author":"Tian","year":"2022","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cyto.2024.156675_b0300","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer","volume":"68","author":"Lin","year":"2019","journal-title":"Gut"},{"issue":"237","key":"10.1016\/j.cyto.2024.156675_b0305","doi-asserted-by":"crossref","first-page":"p. 237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0310","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156675_b0315","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.cyto.2024.156675_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081120","article-title":"Cancer-Derived VEGF-C Increases chemokine production in lymphatic endothelial cells to promote CXCR2-dependent cancer invasion and MDSC recruitment","volume":"11","author":"Chen","year":"2019","journal-title":"Cancers (basel)"},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0325","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.cyto.2024.156675_b0330","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/cas.14521","article-title":"Tumor microenvironment in gastric cancers","volume":"111","author":"Oya","year":"2020","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156675_b0335","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0340","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","article-title":"Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice","volume":"14","author":"Tu","year":"2008","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0345","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000450","article-title":"PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations","volume":"8","author":"Fabian","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"7568","key":"10.1016\/j.cyto.2024.156675_b0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature15251","article-title":"Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth","volume":"525","author":"Zhu","year":"2015","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.cyto.2024.156675_b0355","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1158\/0008-5472.CAN-14-3690","article-title":"Loss of RACK1 promotes metastasis of gastric cancer by inducing a miR-302c\/IL8 signaling loop","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cyto.2024.156675_b0360","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ijc.25562","article-title":"Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models","volume":"128","author":"Ning","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0365","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3892\/ol.2012.1043","article-title":"Expression of C-X-C chemokine receptor types 1\/2 in patients with gastric carcinoma: clinicopathological correlations and significance","volume":"5","author":"Wang","year":"2013","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0370","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13046-022-02366-6","article-title":"A positive feedback loop between gastric cancer cells and tumor-associated macrophage induces malignancy progression","volume":"41","author":"Piao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0375","first-page":"117","article-title":"The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer","volume":"1825","author":"Verbeke","year":"2012","journal-title":"BBA"},{"issue":"7","key":"10.1016\/j.cyto.2024.156675_b0380","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/gutjnl-2016-312888","article-title":"Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses DNA damage and gastric carcinogenesis","volume":"67","author":"Sierra","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0385","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2010.05.101","article-title":"Helicobacter pylori-derived Heat shock protein 60 enhances angiogenesis via a CXCR2-mediated signaling pathway","volume":"397","author":"Lin","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0390","first-page":"508","article-title":"Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels","volume":"69","author":"Goto","year":"1993","journal-title":"Lab. Invest."},{"issue":"13","key":"10.1016\/j.cyto.2024.156675_b0395","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.canlet.2015.01.033","article-title":"CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer","volume":"359","author":"Wei","year":"2015","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cyto.2024.156675_b0405","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00432-007-0225-x","article-title":"CXCL5 overexpression is associated with late stage gastric cancer","volume":"133","author":"Park","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156675_b0410","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0415","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/REP-09-0341","article-title":"Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1","volume":"139","author":"Jovanovi\u0107","year":"2010","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/gut.2005.067454","article-title":"Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis","volume":"55","author":"Yeo","year":"2006","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cyto.2024.156675_b0425","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4321\/S1130-01082006000700006","article-title":"Gastric angiogenesis and Helicobacter pylori infection","volume":"98","author":"Pousa","year":"2006","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"3","key":"10.1016\/j.cyto.2024.156675_b0430","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156675_b0435","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/annonc\/mdq739","article-title":"Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer","volume":"22","author":"Cheng","year":"2011","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156675_b0440","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41389-020-00249-z","article-title":"CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils","volume":"9","author":"Mao","year":"2020","journal-title":"Oncogenesis"},{"issue":"11","key":"10.1016\/j.cyto.2024.156675_b0445","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-18-3567","article-title":"A C-X-C chemokine receptor Type 2-dominated cross-talk between tumor cells and macrophages drives gastric cancer metastasis","volume":"25","author":"Zhou","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0450","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2014.05.004","article-title":"Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro","volume":"69","author":"Li","year":"2014","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.cyto.2024.156675_b0455","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1074\/jbc.M110.100792","article-title":"c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion","volume":"285","author":"Jiao","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.cyto.2024.156675_b0460","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1158\/0008-5472.CAN-04-1177","article-title":"Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2","volume":"64","author":"Ito","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0465","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021040849","article-title":"Steroid Receptor Coactivator-1 (SRC-1) promoted cell metastasis of gastric cancer via VEGFC activator by NF-\u03baB","volume":"32","author":"Zhao","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0470","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ijc.26035","article-title":"Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer","volume":"130","author":"Xu","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.cyto.2024.156675_b0475","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3748\/wjg.v20.i7.1635","article-title":"Treatment of gastric cancer","volume":"20","author":"Orditura","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0480","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156675_b0485","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","article-title":"Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer","volume":"11","author":"Kwon","year":"2021","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0490","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10120-023-01405-1","article-title":"Gastric cancer mesenchymal stem cells via the CXCR2\/HK2\/PD-L1 pathway mediate immunosuppression","volume":"26","author":"Huang","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.cyto.2024.156675_b0495","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12885-015-1793-9","article-title":"The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cyto.2024.156675_b0500","doi-asserted-by":"crossref","first-page":"e0178635","DOI":"10.1371\/journal.pone.0178635","article-title":"Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma","volume":"12","author":"Kasashima","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156675_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154785","article-title":"Characterization of the prognostic values of CXCR family in gastric cancer","volume":"123","author":"Yu","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156675_b0510","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2019.06.007","article-title":"RAS mutations in human cancers: Roles in precision medicine","volume":"59","author":"Murugan","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156675_b0515","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0520","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.cyto.2024.156675_b0525","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.ejca.2009.07.007","article-title":"Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression","volume":"45","author":"Gabellini","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"24","key":"10.1016\/j.cyto.2024.156675_b0530","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1080\/15384101.2019.1689471","article-title":"C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2\/STAT3 pathway in non-small cell lung cancer","volume":"18","author":"Wei","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cyto.2024.156675_b0535","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2017.09.030","article-title":"CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2","volume":"412","author":"Xu","year":"2018","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.cyto.2024.156675_b0540","doi-asserted-by":"crossref","first-page":"28442","DOI":"10.18632\/oncotarget.16086","article-title":"Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0545","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s12032-013-0809-z","article-title":"High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma","volume":"31","author":"Sui","year":"2014","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0550","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.surg.2013.12.037","article-title":"Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma","volume":"155","author":"Sueoka","year":"2014","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0555","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI39397","article-title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts","volume":"120","author":"Ginestier","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cyto.2024.156675_b0560","doi-asserted-by":"crossref","first-page":"14428","DOI":"10.18632\/oncotarget.14803","article-title":"Ladarixin, a dual CXCR1\/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment","volume":"8","author":"Kemp","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0565","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.18632\/aging.102733","article-title":"Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics","volume":"12","author":"Antonosante","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"521","key":"10.1016\/j.cyto.2024.156675_b0570","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0428","article-title":"Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer","volume":"11","author":"Li","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0575","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5340","article-title":"Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian cancer cell viability and migration and tumor growth","volume":"60","author":"Zhang","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156675_b0580","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.21873\/anticanres.12983","article-title":"Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells","volume":"38","author":"Fu","year":"2018","journal-title":"Anticancer Res"},{"issue":"24","key":"10.1016\/j.cyto.2024.156675_b0585","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130850","article-title":"Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC","volume":"4","author":"Kargl","year":"2019","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.cyto.2024.156675_b0590","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-19-2625","article-title":"Inhibition of MDSC Trafficking with SX-682, a CXCR1\/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models","volume":"26","author":"Greene","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0595","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","article-title":"PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0605","doi-asserted-by":"crossref","first-page":"e0228015","DOI":"10.1371\/journal.pone.0228015","article-title":"Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5","volume":"15","author":"Ando","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0610","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 Inhibits Antitumor Immunity by Targeting m(6)A-BHLHE41-CXCL1\/CXCR2 Axis to Promote Colorectal Cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cyto.2024.156675_b0615","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.7150\/thno.57659","article-title":"Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation","volume":"11","author":"He","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.cyto.2024.156675_b0620","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.eururo.2020.10.001","article-title":"Taxane-induced Attenuation of the CXCR2\/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment","volume":"79","author":"Ruiz de Porras","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cyto.2024.156675_b0625","article-title":"CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156675_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107153","article-title":"Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin","volume":"95","author":"Nie","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156675_b0635","doi-asserted-by":"crossref","first-page":"e36545","DOI":"10.1371\/journal.pone.0036545","article-title":"Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer","volume":"7","author":"Wilson","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0640","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ijc.25987","article-title":"Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth","volume":"129","author":"Tazzyman","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"7989","key":"10.1016\/j.cyto.2024.156675_b0645","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41586-023-06696-z","article-title":"Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance","volume":"623","author":"Guo","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cyto.2024.156675_b0650","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3892\/ijo.2016.3371","article-title":"Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil","volume":"48","author":"Wang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156675_b0655","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ajpath.2016.07.024","article-title":"CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma","volume":"186","author":"Kasashima","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156675_b0660","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcmgh.2020.10.015","article-title":"Inflammation-Associated Senescence Promotes Helicobacter pylori-Induced Atrophic Gastritis","volume":"11","author":"Cai","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2024.156675_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cyto.2024.156675_b0670","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10637-023-01410-2","article-title":"CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial","volume":"42","author":"Armstrong","year":"2024","journal-title":"Invest. New Drugs"},{"issue":"18","key":"10.1016\/j.cyto.2024.156675_b0675","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1158\/1078-0432.CCR-16-2748","article-title":"Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-negative metastatic breast cancer","volume":"23","author":"Schott","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2024.156675_b0680","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-021-06367-5","article-title":"A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)","volume":"190","author":"Goldstein","year":"2021","journal-title":"Breast Cancer Res.. Treat"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:16:28Z","timestamp":1786792588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":136,"alternative-id":["S1043466624001789"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156675","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CXCR2 chemokine receptor: A new target for gastric cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156675"}}